FSD3958 Use of Complementary and Alternative Medicine in Finland 2022
Aineisto on käytettävissä (C) vain tutkimukseen ja ylempiin opinnäytteisiin (esim. väitöstutkimukseen, pro graduun ja ylemmän AMK-tutkinnon opinnäytetyöhön). Aineistoa ei saa käyttää opetukseen, opiskeluun (esim. harjoitustöihin) tai alempiin opinnäytteisiin.
Lataa aineisto täältä
Muunkieliset kuvailuversiot
Aineistoon liittyvät tiedostot
Aineiston nimi
Use of Complementary and Alternative Medicine in Finland 2022
Aineistonumero
FSD3958
Pysyvät tunnisteet
https://urn.fi/urn:nbn:fi:fsd:T-FSD3958https://doi.org/10.60686/t-fsd3958
Aineiston laatu
Kvantitatiivinen aineisto
Tekijät
- Aarva, Pauliina (Yhdistävä Lääketiede ry)
Sisällön kuvaus
The study surveyed Finns' views on complementary and alternative medicine.
At the beginning of the survey, respondents were asked about their experiences of visiting different healthcare professionals by asking whether they had visited one or more healthcare professionals (e.g., doctor, chiropractor, homeopath, massage therapist) during the past 12 months. Following this, the respondents were asked about the number of visits, the main reason for the visit, and the perceived benefits of the visit. The respondents were also asked whether a doctor had recommended any complementary or alternative medicine to them in the past 12 months. Next, the respondents' use of natural remedies was surveyed by asking what natural remedies they had used or what products their doctor had recommended for use during the past 12 months. The respondents were also asked whether they had used any self-help practices (e.g., meditation/mindfulness, yoga, sauna, art) in the past 12 months. The respondents were then asked about the frequency of using self-help practices, the most important reason for use, and the perceived benefits of use.
The respondents were then asked more generally about the benefits or harms they had experienced from using complementary and alternative medicine. In addition, the survey explored the impact of the COVID-19 pandemic on the use of complementary and alternative medicine, natural remedies, and self-help practices. After this, the respondents were presented with various statements about health and the disease treatment, which they were asked to evaluate. They were also asked to assess their own health status. Additionally, the survey asked whether the respondents intended to use complementary medicine in the future and whether their use of complementary medicine had previously affected or delayed their access to medical care. At the end of the survey, the respondents were asked to evaluate how important different values are to them (e.g., power, pleasure, traditions, security).
The background variables in the data include the respondent's occupational status, stage of life, age group, household size, household income, level of education, position on the right-left axis, marital status, gender, native language, and several different regional variables.
Asiasanat
beliefs; complementary therapies; diseases; health status; lifestyle and health; medical sciences; medical self-treatment; medical treatment methods; naturopathy; well-being (health)
Tieteenala/Aihealue
- Social sciences (OKM:n tieteenalaluokitus)
- Medical and health sciences (OKM:n tieteenalaluokitus)
- Medication and treatment (CESSDAn aihepiiriluokitus)
Sarja
Individual datasetsJakelija
Finnish Social Science Data Archive
Käyttöoikeudet
The dataset is (C) available only for research including master's theses.
Kerääjät
- Kantar TNS Finland
Rahoittajat
- Child and Nature Foundation
Ajallinen kattavuus
2022
Aineistonkeruun ajankohta
2022-12-02 – 2022-12-19
Maa
Finland
Kohdealue
Finland
Havaintoyksikkötyyppi
Individual
Perusjoukko/otos
People aged 16 and over residing in Finland (excluding the Åland Islands)
Tutkimuksen aikaulottuvuus
Cross-section
Otantamenetelmä
Non-probability: Quota
The survey was sent via email between December 2 and 19, 2022, to 11,507 members of Kantar Oy's online panel, which had approximately 30,000 members in December 2022. A total of 3,244 individuals aged 16 and over living in mainland Finland participated in the study. The quota was selected to correspond to national population statistics.
Keruumenetelmä
Self-administered questionnaire: Web-based (CAWI)
Keruuväline tai –ohje
Structured questionnaire
Vastausprosentti
28.19
Datatiedostojen kieli
Aineistopaketti voi sisältää samoja tiedostoja eri kielisinä.
Aineisto sisältää datatiedostoja seuraavilla kielillä: suomi.
Tietoarkisto kääntää kvantitatiivisia datatiedostoja englanniksi. Lisätietoja käännöspyynnön jättämisestä.
Datan versio
1.0
Aineiston käytössä huomioitavaa
The researchers have anonymised the data by removing open-ended response variables VBJ and VCP.
To prevent identification of respondents, the continuous age variable was removed from the data at FSD, and open-ended responses were reviewed and anonymised where necessary. Identifiers removed at FSD were marked with [square brackets].
Painokertoimet
The data includes a weight variable that weights the data according to the respondent's gender, age, and place of residence.
Viittausvaatimus
The data and its creators shall be cited in all publications and presentations for which the data have been used. The bibliographic citation may be in the form suggested by the archive or in the form required by the publication.
Malliviittaus
Aarva, Pauliina (Yhdistävä Lääketiede ry): Use of Complementary and Alternative Medicine in Finland 2022 [dataset]. Data version 1.0 (2025-08-15). Finnish Social Science Data Archive [distributor]. DOI: https://doi.org/10.60686/t-fsd3958; URN: https://urn.fi/urn:nbn:fi:fsd:T-FSD3958
Julkaisusta tiedottaminen
Notify FSD of all publications where you have used the data by sending the citation information to user-services.fsd@tuni.fi.
Varaumat
The original data creators and the archive bear no responsibility for any results or interpretations arising from the reuse of the data.
Julkaisut aineistosta
Aineiston kuvailu koneluettavassa DDI-C 2.5 -formaatissa
Aineiston kuvailu on lisensoitu Creative Commons Nimeä 4.0 Kansainvälinen -lisenssin mukaisesti.